[The study of human rhinovirus in infants with lower respiratory tract infections]

Huan-huan Wang1, Nai-ying Mao, Song-tao Xu

  • 1Department of Neurobiology, Taishan Medical College, Taian 271000, China.

Insights

Human rhinovirus infections are common in Beijing infants, particularly those under two years old, leading to lower respiratory tract infections like pneumonia. This seasonal virus spreads quickly, necessitating hospital infection control measures.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Epidemiology

Context:

  • Human rhinovirus (HRV) is a significant cause of respiratory illness in children.
  • Understanding HRV prevalence and associated conditions in specific geographic areas is crucial for public health.
  • Beijing experiences seasonal peaks in respiratory infections among its pediatric population.

Purpose:

  • To investigate the prevalence and clinical characteristics of human rhinovirus (HRV) infections in hospitalized infants and children in Beijing.
  • To determine the association between HRV and lower respiratory tract infections, including pneumonia.
  • To identify the age groups most affected by HRV.

Summary:

  • A study of 240 hospitalized children in Beijing found a 29.58% HRV positive rate using real-time reverse transcription PCR (RT-PCR).
  • Pneumonia was the predominant diagnosis (86.67%), with most HRV cases occurring in children under two years old.
  • HRV infections peaked in spring and winter, with highest incidence in infants aged 13-18 months and those 24 months and older.

Impact:

  • This research highlights HRV as a key pathogen in pediatric lower respiratory tract infections in Beijing.
  • Findings underscore the importance of age-specific vulnerability, with infants under two being the primary risk group.
  • The study emphasizes the need for enhanced infection control protocols in healthcare settings to prevent HRV transmission.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...